Fintel reports that on February 11, 2025, BMO Capital downgraded their outlook for Q32 Bio (NasdaqGM:QTTB) from Outperform to Market Perform. Analyst Price Forecast Suggests 458.11% Upside As of ...

BMO Capital Markets highlighted the potential risks faced by Real Estate Investment Trusts (REITs) specializing in Skilled Nursing Facilities (SNFs) due to possible changes in Federal Medical ...

"This was a decent fourth quarter GDP print that highlighted rock-solid consumer spending and a sustainable economic ...

Wednesday's consumer-price index for January looms in the minds of bond-market participants, as investors and traders also remain focused on the prospect of trade wars between the U.S. and other ...

BMO Capital lowered the firm’s price target on Harley-Davidson (HOG) to $35 from $40 and keeps an Outperform rating on the ...

BMO Capital initiated coverage of Flowco (FLOC) with an Outperform rating and $33 price target The firm likes the company’s “differentiated” ...

BMO Capital raised the firm’s price target on IGM Financial (IGIFF) to C$48 from C$47 and keeps a Market Perform rating on the shares.Maximize ...

Verticals (NASDAQ:IIIV – Free Report) had its price target lifted by BMO Capital Markets from $22.00 to $26.00 in a research note released on Monday,Benzinga reports. They currently have a market ...

O’Reilly Automotive (NASDAQ:ORLY – Free Report) had its price target lifted by BMO Capital Markets from $1,400.00 to ...

BMO analysts are not convinced that Fluence Energy stock will swiftly recover as FLNC crashes after disappointing Q1 earnings.

BMO Capital Markets downgraded Everest Group to Market Perform due to deeper underwriting issues and a $1.7B reserve charge, ...